189 related articles for article (PubMed ID: 17901563)
1. The highly expressed and inducible endogenous NAD(P)H:quinone oxidoreductase 1 in cardiovascular cells acts as a potential superoxide scavenger.
Zhu H; Jia Z; Mahaney JE; Ross D; Misra HP; Trush MA; Li Y
Cardiovasc Toxicol; 2007; 7(3):202-11. PubMed ID: 17901563
[TBL] [Abstract][Full Text] [Related]
2. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger.
Siegel D; Gustafson DL; Dehn DL; Han JY; Boonchoong P; Berliner LJ; Ross D
Mol Pharmacol; 2004 May; 65(5):1238-47. PubMed ID: 15102952
[TBL] [Abstract][Full Text] [Related]
3. Role of Nrf2 signaling in regulation of antioxidants and phase 2 enzymes in cardiac fibroblasts: protection against reactive oxygen and nitrogen species-induced cell injury.
Zhu H; Itoh K; Yamamoto M; Zweier JL; Li Y
FEBS Lett; 2005 Jun; 579(14):3029-36. PubMed ID: 15896789
[TBL] [Abstract][Full Text] [Related]
4. Role of NAD(P)H:quinone oxidoreductase 1 on tumor necrosis factor-alpha-induced migration of human vascular smooth muscle cells.
Lee SO; Chang YC; Whang K; Kim CH; Lee IS
Cardiovasc Res; 2007 Nov; 76(2):331-9. PubMed ID: 17669387
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of NAD(P)H:quinone oxidoreductase I (NQO1) inhibition by mitomycin C in vitro and in vivo.
Gustafson DL; Siegel D; Rastatter JC; Merz AL; Parpal JC; Kepa JK; Ross D; Long ME
J Pharmacol Exp Ther; 2003 Jun; 305(3):1079-86. PubMed ID: 12649308
[TBL] [Abstract][Full Text] [Related]
6. Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition.
Guo W; Reigan P; Siegel D; Zirrolli J; Gustafson D; Ross D
Cancer Res; 2005 Nov; 65(21):10006-15. PubMed ID: 16267026
[TBL] [Abstract][Full Text] [Related]
7. 5-Methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, exhibits activity against human pancreatic cancer in vitro and in vivo.
Dehn DL; Siegel D; Zafar KS; Reigan P; Swann E; Moody CJ; Ross D
Mol Cancer Ther; 2006 Jul; 5(7):1702-9. PubMed ID: 16891456
[TBL] [Abstract][Full Text] [Related]
8. Coordinated upregulation of a series of endogenous antioxidants and phase 2 enzymes as a novel strategy for protecting renal tubular cells from oxidative and electrophilic stress.
Zhu H; Zhang L; Amin AR; Li Y
Exp Biol Med (Maywood); 2008 Jun; 233(6):753-65. PubMed ID: 18408143
[TBL] [Abstract][Full Text] [Related]
9. Evidence for NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated quinone-dependent redox cycling via plasma membrane electron transport: A sensitive cellular assay for NQO1.
Tan AS; Berridge MV
Free Radic Biol Med; 2010 Feb; 48(3):421-9. PubMed ID: 19932748
[TBL] [Abstract][Full Text] [Related]
10. Arsenite and cadmium, but not chromium, induce NAD(P)H:quinone oxidoreductase 1 through transcriptional mechanisms, in spite of post-transcriptional modifications.
Elbekai RH; El-Kadi AO
Toxicol In Vitro; 2008 Aug; 22(5):1184-90. PubMed ID: 18474416
[TBL] [Abstract][Full Text] [Related]
11. Development of indolequinone mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1): NQO1 inhibition and growth inhibitory activity in human pancreatic MIA PaCa-2 cancer cells.
Reigan P; Colucci MA; Siegel D; Chilloux A; Moody CJ; Ross D
Biochemistry; 2007 May; 46(20):5941-50. PubMed ID: 17455910
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide synthase and NAD(P)H oxidase modulate coronary endothelial cell growth.
Bayraktutan U
J Mol Cell Cardiol; 2004 Feb; 36(2):277-86. PubMed ID: 14871555
[TBL] [Abstract][Full Text] [Related]
13. Biochemical, cytotoxic, and genotoxic effects of ES936, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, in cellular systems.
Dehn DL; Siegel D; Swann E; Moody CJ; Ross D
Mol Pharmacol; 2003 Sep; 64(3):714-20. PubMed ID: 12920209
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic and molecular aspects of the antioxidant effect of menadione in hepatic microsomes.
Tampo Y; Yonaha M
Arch Biochem Biophys; 1996 Oct; 334(1):163-74. PubMed ID: 8837752
[TBL] [Abstract][Full Text] [Related]
15. ES936 stimulates DNA synthesis in HeLa cells independently on NAD(P)H:quinone oxidoreductase 1 inhibition, through a mechanism involving p38 MAPK.
González-Aragón D; Alcaín FJ; Ariza J; Jódar L; Barbarroja N; López-Pedrera C; Villalba JM
Chem Biol Interact; 2010 Jul; 186(2):174-83. PubMed ID: 20433816
[TBL] [Abstract][Full Text] [Related]
16. The role of NAD(P)H:quinone oxidoreductase in quinone-mediated p21 induction in human colon carcinoma cells.
Qiu XB; Cadenas E
Arch Biochem Biophys; 1997 Oct; 346(2):241-51. PubMed ID: 9343371
[TBL] [Abstract][Full Text] [Related]
17. Role of NADPH cytochrome P450 reductase in activation of RH1.
Begleiter A; Leith MK; Patel D; Hasinoff BB
Cancer Chemother Pharmacol; 2007 Oct; 60(5):713-23. PubMed ID: 17256129
[TBL] [Abstract][Full Text] [Related]
18. 1-Hydroxyethyl radical formation during NADPH- and NADH-dependent oxidation of ethanol by human liver microsomes.
Rao DN; Yang MX; Lasker JM; Cederbaum AI
Mol Pharmacol; 1996 May; 49(5):814-21. PubMed ID: 8622631
[TBL] [Abstract][Full Text] [Related]
19. Antioxidants and phase 2 enzymes in cardiomyocytes: Chemical inducibility and chemoprotection against oxidant and simulated ischemia-reperfusion injury.
Cao Z; Zhu H; Zhang L; Zhao X; Zweier JL; Li Y
Exp Biol Med (Maywood); 2006 Sep; 231(8):1353-64. PubMed ID: 16946404
[TBL] [Abstract][Full Text] [Related]
20. High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase.
Ungvari Z; Csiszar A; Huang A; Kaminski PM; Wolin MS; Koller A
Circulation; 2003 Sep; 108(10):1253-8. PubMed ID: 12874194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]